Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Diabetic Foot

• Multi-center Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot Ulcer
• Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
• Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients
• Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot
• The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer
• Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?
• Fitostimoline® Hydrogel Versus Saline Gauze Dressing in Diabetic Foot Ulcers
• Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds
• Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.
• A Feasibility Trial to Investigate the Safety and Between-group Effect Size of Stimulan-VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis of the Forefoot.
• Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)
• Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
• Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds
• Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients
• Immunonutrition for Diabetic Foot Ulcers
• Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
• Multi-center Study to Assess Safety, Tolerability and Efficacy of MBN-101 in Patients With Moderate/Severe DFI
• A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer
• Treating Diabetic Foot Ulcers, Comparing Two Topical Antimicrobial Agents, Dakin´s and Prontosan
• Evaluating the Healing of Diabetic Foot Ulcers With Compounded Anti-Infective Irrigation Therapy
• Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)
• Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
• A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs.
• POPLITEAL SCIATIC NERVE BLOCK FOR DIABETIC FOOT SURGERIES
• A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers
• Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers
• Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer
• Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia
• Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients
• Intensive Glycemic Control For Diabetic Foot Ulcer Healing
• The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers
• Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes
• Application of S26E for Diabetic Foot Ulcer Healing
• Ceftriaxone as Home IV for Staph Infections
• PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS
• Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers
• A Randomized Trial on Platelet Rich Plasma Versus Saline Dressing of Diabetic Foot Ulcers
• Effect of Anesthesia Technique on Early Outcome in Diabetic Patients Undergoing Lower Extremity Amputation
• Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers
• Effect of Adding Dexamethasone to Intrathecal Bupivacaine on Blood Sugar of Patients Undergoing Diabetic Foot Surgeries
• The Healing Effects Of Honey and Hydrogel Products On The Diabetic Foot
• Intensive Versus Conventional Glycemic Control in Diabetic Foot Ulcer Healing
• Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer
• Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers
• TWB-103 for Treating Lower Limb Ulcers on Patients With DM
• Less Infections for the Diabetic Foot
• Clinical Evaluation and Generalized Application of "Qing-Hua-Bu" Three Dynamic Sequential Therapy of Diabetic Ulcer
• Preventing Diabetic Foot Ulcers Through Cleaner Feet
• Beta Adrenergic Antagonist for the Healing of Chronic DFU
• Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers
• Chlorhexidine Gluconate Solution at 0.125% vs Placebo for the Healing of Grade IIB Ulcers of Diabetic Foot
• Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers
• Safety and Efficacy of Three Local Block Techniques for Diabetic Foot Surgery
• Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers
• The Effects of BAY1193397 on Skin Capillary Blood Flow and Transcutaneous Oxygen Pressure
• Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2
• Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs
• The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
• Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabetic Foot Ulcers
• Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers
• Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus
• A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI
• Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin
• ENERGI-F703 for Diabetic Foot Ulcers Phase II Study
• A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
• A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
• Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus
• Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
• Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers
• Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers
• Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
• Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
• Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
• Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
• Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
• Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment
• Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients
• Topical Erythropoietin Hydrogel Formulation for Diabetic Foot Ulcers
• The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers
• A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer
• Effect of Topic Pirfenidone in Diabetic Ulcers
• Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
• EZCast-DFU Study With Portal for Application of Topical Medications
• Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis
• Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
• Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
• Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
• Effect of Local Application of Boron on Diabetic Foot Ulcers
• Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers
• Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
• Cutaneous Microcirculation and Diabetic Foot
• Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection
• Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
• Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers
• Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
• Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
• CSTC1 for Diabetic Foot Ulcers Phase II Study
• BE Study of Metformin GSK 500mg
• Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia
• Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
• Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
• Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
• Diabetic Foot Infection Antibiotic Study
• Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers
• A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)
• Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers
• The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 Diabetes
• Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)
• Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers
• The Relationship of Hemoglobin A1c and Diabetic Wound Healing
• Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study
• Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
• Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes
• The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study
• The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study
• Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot
• Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment
• A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
• Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers
• A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers
• Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers
• Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
• Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
• Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
• The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers
• Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer
• Effects of N-acetylcysteine on Diabetic Foot Oxygenation
• A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
• Santyl vs. Sharp Debridement of Diabetic Foot Wounds
• Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers
• A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia
• Safety Study of Topical Human FGF-1 for Wound Healing
• Trial of Herb Yuyang Ointment to Diabetic Foot Ulcer
• Urokinase Therapy in Patients With Diabetic Foot Syndrome
• The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers
• Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
• The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)
• Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers
• Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers
• Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers
• Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
• Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients
• The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers
• Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer
• Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers
• Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer
• MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
• MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
• Urokinase Therapy in Diabetic Foot Syndrome
• Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections
• Hyperbaric Oxygen, Oxidative Stress, NO Bioavailability and Tissue Oxygenation
• Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers
• Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers
• Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON
• Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
• Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients
• Herbal Preparation Used as Adjuvant Therapy on Diabetic Ulcers
• TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers
• Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
• A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
• Wound Healing Effects of HO/03/03 In Patients With Diabetic Neuropathic Plantar and Venous Ulcers, Pilot Study.
• Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers
• Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers
• Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers
• Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)
• Improving Diabetic Foot Ulcers With Atorvastatin
• A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
• Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections
• A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX